Change of Adviser

20 May 2020

20 May 2020

 

Redx Pharma plc

(“Redx” or “the Company”)

Change of Adviser

 

The Company announces that SPARK Advisory Partners Limited has been appointed as the Company’s nominated adviser with immediate effect.

 

For further information, please contact:

Redx Pharma Plc 

T: +44 1625 469 918

Iain Ross, Chairman

Lisa Anson, Chief Executive

SPARK Advisory Partners Limited (Nominated Adviser)

 T: +44 203 368 3550

Matt Davis/Andrew Emmott

WG Partners LLP (Broker)

T: +44 20 3705 9330

Claes Spång/Chris Lee/David Wilson

FTI Consulting

T: +44 20 3727 1000

Simon Conway/Ciara Martin

 

 

 

About Redx Pharma Plc

Redx is a UK based biotechnology company whose shares are traded on AIM (AIM:REDX). Redx’s vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.

If you would like to sign up to regular alerts from Redx Pharma, please follow this link https://www.redxpharma.com/investors/email-alerts/